Regeneron Pharmaceuticals, Inc.

NASDAQ:REGN

666.87 (USD) • At close March 14, 2025
Bedrijfsnaam Regeneron Pharmaceuticals, Inc.
Symbool REGN
Munteenheid USD
Prijs 666.87
Beurswaarde 71,693,859,960
Dividendpercentage 0%
52-weken bereik 642 - 1,211.2
Industrie Biotechnology
Sector Healthcare
CEO Dr. Leonard S. Schleifer M.D., Ph.D.
Website https://www.regeneron.com

An error occurred while fetching data.

Over Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macular edema following retinal vein occlusion, including macular edema following

Vergelijkbare Aandelen

Intuitive Surgical, Inc. logo

Intuitive Surgical, Inc.

ISRG

484.44 USD

Gilead Sciences, Inc. logo

Gilead Sciences, Inc.

GILD

111.44 USD

Vertex Pharmaceuticals Incorporated logo

Vertex Pharmaceuticals Incorporated

VRTX

504.77 USD

Moderna, Inc. logo

Moderna, Inc.

MRNA

34.62 USD

Illumina, Inc. logo

Illumina, Inc.

ILMN

85.6 USD

Walgreens Boots Alliance, Inc. logo

Walgreens Boots Alliance, Inc.

WBA

11.23 USD

IDEXX Laboratories, Inc. logo

IDEXX Laboratories, Inc.

IDXX

415.3 USD

Biogen Inc. logo

Biogen Inc.

BIIB

139.44 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)